{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:40:08Z","timestamp":1790692808630,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","award":["IG18855"],"award-info":[{"award-number":["IG18855"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Progetto di Ricerca di Ateneo 2014","award":["PDA141311"],"award-info":[{"award-number":["PDA141311"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.antiviral.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T02:03:50Z","timestamp":1549764230000},"page":"52-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity."],"prefix":"10.1016","volume":"164","author":[{"given":"Anna","family":"Luganini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-8045","authenticated-orcid":false,"given":"Beatrice","family":"Mercorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pal\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gribaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Loregian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JVI.79.3.1428-1437.2005","article-title":"The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early protein IE2\/IEP86 affects temporal viral gene expression","volume":"79","author":"Barrasa","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2016.12.006","article-title":"Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins","volume":"138","author":"Beelontally","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2018.08.002","article-title":"Meeting report: 31st international conference on antiviral Research","volume":"158","author":"Bray","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"22075","DOI":"10.1074\/jbc.273.34.22075","article-title":"The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein","volume":"273","author":"Bresnahan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.02.006_bib5","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.3390\/v10080405","article-title":"Maternal immunity and the natural history of congenital human cytomegalovirus infection","volume":"10","author":"Britt","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2018.09.003","article-title":"New therapies for human cytomegalovirus infections","volume":"159","author":"Britt","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1462-5822.2007.00936.x","article-title":"Activation of the virus-induced IKK\/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells","volume":"9","author":"Caposio","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.02141-09","article-title":"The Elk-1 and Serum Response Factor binding sites in the Major Immediate-Early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-\u03baB sites in proliferating cells","volume":"84","author":"Caposio","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib9","doi-asserted-by":"crossref","first-page":"11092","DOI":"10.1128\/JVI.01141-15","article-title":"Inactivation of the human cytomegalovirus US20 gene hampers productive viral replication in endothelial Cells","volume":"89","author":"Cavaletto","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.intimp.2011.06.002","article-title":"Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis)","volume":"11","author":"Cecil","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib11","doi-asserted-by":"crossref","first-page":"28420","DOI":"10.1074\/jbc.M109.012674","article-title":"Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice","volume":"284","author":"Cui","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.02.006_bib12","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/JVI.78.9.4498-4507.2004","article-title":"Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter","volume":"78","author":"DeMeritt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2014.10.011","article-title":"Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle","volume":"113","author":"Gardner","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002498","article-title":"The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication","volume":"8","author":"Gariano","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.1995.tb08915.x","article-title":"Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection","volume":"89","author":"Gibellini","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib16","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1099\/0022-1317-83-12-2983","article-title":"Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts","volume":"83","author":"Gribaudo","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/QCO.0000000000000409","article-title":"Viral infections in solid organ transplant recipients: novel updates and a review of the classics","volume":"30","author":"Haidar","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.02.006_bib19","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1128\/JVI.72.7.5481-5492.1998","article-title":"Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2","volume":"72","author":"Harel","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib20","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.bmcl.2006.12.085","article-title":"Antiviral activity of berberine and related compounds against human cytomegalovirus","volume":"17","author":"Hayashi","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ptr.5693","article-title":"Berberis vulgaris and berberine: an update review","volume":"30","author":"Imenshahidi","year":"2016","journal-title":"Phytother Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(99)00002-9","article-title":"Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole on HCMV DNA replication and permissive infection","volume":"41","author":"Johnson","year":"1999","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/JVI.74.3.1158-1167.2000","article-title":"Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38","volume":"74","author":"Johnson","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1099\/0022-1317-82-3-493","article-title":"The role of MKK1\/2 kinase activity in human cytomegalovirus infection","volume":"82","author":"Johnson","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/JVI.70.1.373-382.1996","article-title":"Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection","volume":"70","author":"Kerry","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib26","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/MCB.13.2.1238","article-title":"In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins","volume":"13","author":"Klucher","year":"1993","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of berberine: an update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chembiol.2005.12.002","article-title":"Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase","volume":"13","author":"Loregian","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib29","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/AAC.01730-09","article-title":"The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein","volume":"54","author":"Loregian","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.02.006_bib30","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1365-2672.2008.03927.x","article-title":"New cell-based indicator assays for the detection of human cytomegalovirus infection and screening of inhibitors of viral immediate-early 2 protein activity","volume":"105","author":"Luganini","year":"2008","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3389\/fmicb.2016.00715","article-title":"Bioactive molecules released from cells infected with the human cytomegalovirus","volume":"7","author":"Luganini","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib33","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.02.006_bib34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2019.02.006_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/AAC.00988-08","article-title":"A 6-aminoquinolone compound, WC5, with potent and selective anti-human cytomegalovirus activity","volume":"53","author":"Mercorelli","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.02.006_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pharmthera.2011.04.007","article-title":"Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives","volume":"131","author":"Mercorelli","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2019.02.006_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-62703-788-4_18","article-title":"Approaches for the generation of new anti-cytomegalovirus agents: identification of protein protein interaction inhibitors and compounds against the HCMV IE2 protein","volume":"1119","author":"Mercorelli","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib38","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.03309-14","article-title":"The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication","volume":"58","author":"Mercorelli","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.02.006_bib39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.chembiol.2015.12.012","article-title":"Drug repurposing approach identifies inhibitors of the prototypic viral transcription factor IE2 that block human cytomegalovirus replication","volume":"23","author":"Mercorelli","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2017.12.014","article-title":"Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein","volume":"150","author":"Mercorelli","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug repurposing for viral infectious diseases: how far are we?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/JVI.66.1.27-36.1992","article-title":"Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3","volume":"66","author":"Messerle","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.ircmb.2017.07.011","article-title":"Transcription: insights from the HIV-1 promoter","volume":"335","author":"Ne","year":"2018","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib44","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/0008-5472.CAN-08-0511","article-title":"Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis","volume":"68","author":"Pandey","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/905749","article-title":"Application of berberine on treating type 2 diabetes mellitus","volume":"2015","author":"Pang","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib46","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1021\/jm400914r","article-title":"A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter","volume":"56","author":"Perrone","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.02.006_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOT.0000000000000541","article-title":"Drug-resistant cytomegalovirus: clinical implications of specific mutations","volume":"23","author":"Razonable","year":"2018","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.antiviral.2019.02.006_bib48","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/323425","article-title":"Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns","volume":"184","author":"Revello","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.02.006_bib49","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1038\/s41467-018-04444-w","article-title":"Male germ cells support long-term propagation of Zika virus","volume":"9","author":"Robinson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.02.006_bib50","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1128\/JVI.79.5.2754-2767.2005","article-title":"Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements","volume":"79","author":"Sampaio","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(01)00126-7","article-title":"Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?","volume":"49","author":"Scholz","year":"2001","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.intimp.2015.04.045","article-title":"Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine","volume":"27","author":"Shin","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib53","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/AAC.02427-14","article-title":"Downregulation of cellular c-Jun N-terminal protein kinase and NF-kappaB activation by berberine may result in inhibition of herpes simplex virus replication","volume":"58","author":"Song","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.02.006_bib54","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Immediate-early viral gene regulation and function","author":"Stinski","year":"2007"},{"key":"10.1016\/j.antiviral.2019.02.006_bib55","first-page":"133","article-title":"Functional roles of the human cytomegalovirus essential IE86 protein","volume":"325","author":"Stinski","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","article-title":"Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses","volume":"126","author":"Varghese","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.006_bib57","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/JVI.01382-16","article-title":"The antiviral alkaloid berberine reduces chikungunya virus-induced mitogen-activated protein kinase signaling","volume":"90","author":"Varghese","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.006_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12985-016-0674-4","article-title":"Berberine inhibits enterovirus 71 replication by downregulating the MEK\/ERK signaling pathway and autophagy","volume":"14","author":"Wang","year":"2017","journal-title":"Virol. J."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218305977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218305977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T06:04:22Z","timestamp":1606457062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218305977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":57,"alternative-id":["S0166354218305977"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}